Net profit of Novartis India rose 29.05% to Rs 23.68 crore in the quarter ended September 2023 as against Rs 18.35 crore during the previous quarter ended September 2022. Sales declined 22.42% to Rs 78.76 crore in the quarter ended September 2023 as against Rs 101.52 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales78.76101.52 -22 OPM %21.4716.08 - PBDT33.0822.69 46 PBT32.4321.31 52 NP23.6818.35 29 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 27 October 2023.Powered by Capital Market - Live News

Net profit of Novartis India declined 61.32% to Rs 20.26 crore in the quarter ended June 2023 as against Rs 52.38 crore during the previous quarter ended June 2022. Sales declined 25.07% to Rs 90.60 crore in the quarter ended June 2023 as against Rs 120.92 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales90.60120.92 -25 OPM %19.1226.30 - PBDT29.3357.82 -49 PBT27.7756.52 -51 NP20.2652.38 -61 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 26 July 2023.Powered by Capital Market - Live News

Novartis India announced that the 75th Annual General Meeting (AGM) of the company will be held on 28 July 2023.Powered by Capital Market - Live News